Exercise deprivation increases negative mood in exercise-addicted subjects and modifies their biochemical markers

Physiology and Behavior

Volumn 156, Issue , 2016, Pages 182-190

  Antunes, Hanna Karen Moreira ^a,b   Leite, Geovana Silva Fogaça ^b   Lee, Kil Sun ^a   Barreto, Amaury Tavares ^b   Santos, Ronaldo Vagner Thomatieli dos ^a,b   Souza, Helton de Sá ^a,b   Tufik, Sergio ^a   de Mello, Marco Tulio ^a,b,c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Centro de Estudos em Psicobiologia e Exercício CEPE   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Anandamide; Exercise; Exercise addiction; Mood

Indexed keywords

ANANDAMIDE; BETA ENDORPHIN; BIOCHEMICAL MARKER; CREATINE KINASE; LACTATE DEHYDROGENASE; AMIDE; ARACHIDONIC ACID DERIVATIVE; BIOLOGICAL MARKER; ENDOCANNABINOID;

ACCELEROMETER; ACTIMETRY; ADULT; AEROBIC CAPACITY; AFFECT; ANGER; ARTICLE; ATHLETE; BLOOD SAMPLING; BODY COMPOSITION; CLINICAL ARTICLE; CONFUSION; CONTROLLED STUDY; DEPRESSION; EXERCISE; FATIGUE; HUMAN; LUNG GAS EXCHANGE; LUNG VENTILATION; MALE; MOOD; OXYGEN CONSUMPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RUNNING; TRAINING; VALIDATION PROCESS; YOUNG ADULT; BLOOD; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

ADULT; AFFECT; ARACHIDONIC ACIDS; ATHLETES; BETA-ENDORPHIN; BIOMARKERS; DEPRESSION; ENDOCANNABINOIDS; EXERCISE; HUMANS; MALE; OXYGEN CONSUMPTION; POLYUNSATURATED ALKAMIDES;

EID: 84955560304     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2016.01.028     Document Type: Article

References (53)

1. Warburton D.E., Nicol C.W., Bredin S.S. Health benefits of physical activity: the evidence. CMAJ 2006, 174:801-809. 10.1503/cmaj.051351.
2. De Mello M.T., Lemos Vde A., Antunes H.K., Bittencourt L., Santos-Silva R., Tufik S. Relationship between physical activity and depression and anxiety symptoms: a population study. J. Affect. Disord. 2013, 149:241-246. 10.1016/j.jad.2013.01.035.
3. Antunes H.K.M., De Mello M.T., Lemos V.A.L., Santos-Galduróz R.F., Galdieri L.C., Bueno O.F.A., Tufik S., D'Almeida V. Aerobic physical exercise improved the cognitive function of elderly males but did not modify their blood homocysteine levels. Dement. Geriatr. Cogn. Disord. Extra. 2015, 5:13-24. 10.1159/000369160.
4. Dietrich A., McDaniel W.F. Endocannabinoids and exercise. Br. J. Sports Med. 2004, 38:536-541. 10.1136/bjsm.2004.011718.
5. Hausenblas H.H., Symon Downs D. Exercise dependence: a systematic review. Psychol. Sport Exercise 2002, 3:89-123.
6. Veale D. Exercise dependence. Br. J. Addict. 1987, 82:735.
7. Hausenblas H.H., Giacobbi P.R. Relationship between exercise dependence symptoms and personality. Personal. Individ. Differ. 2004, 36:1265-1273.
8. Berczik K., Szabó A., Griffiths M.D., Kurimay T., Kun B., Urbán R., Demetrovics Z. Exercise addiction: symptoms, diagnosis, epidemiology, and etiology. Subst. Use Misuse 2012, 47:403-417. 10.3109/10826084.2011.639120.
9. Weinstein A., Weinstein Y. Exercise addiction - diagnosis, bio-psychological mechanisms and treatment issues. Curr. Pharm. Des. 2014, 20:4062-4069. 10.2174/13816128113199990614.
10. Egorov A.Y., Szabo A. The exercise paradox: an interactional model for a clearer conceptualization of exercise addiction. J. Behav. Addict. 2013, 2:199-208. 10.1556/JBA.2.2013.4.2.
11. Szabo A., Griffiths M.D., de La Vega Marcos R., Mervó B., Demetrovics Z. Methodological and conceptual limitations in exercise addiction research. Yale J. Biol. Med. 2015, 88(3):303-308.
12. Hamer M., Karageorghis C.L. Psychobiological mechanisms of exercise dependence. Sports Med. 2007, 37:477-484. 10.2165/00007256-200737060-00002.
13. Smith M.A., Yancey D.L. Sensitivity to the effects of opioids in rats with free access to exercise wheels: mu opioid tolerance and physical dependence. Psychopharmacology 2003, 167:426-434. 10.1007/s00213-003-1471-5.
14. Boecker H., Sprenger T., Spilker M.E., Henriksen G., Koppenhoefer M., Wagner K.J., Valet M., Berthele A., Tolle T.R. The runner's high: opioidergic mechanisms in the human brain. Cereb. Cortex 2008, 18:2523-2531. 10.1093/cercor/bhn013.
15. Kop W.J., Weinstein A.A., Deuster P.A., Whittaker K.S., Tracy R.P. Inflammatory markers and negative mood symptoms following exercise withdrawal. Brain Behav. Immun. 2008, 22:1190-1196. 10.1016/j.bbi.2008.05.011.
16. Poole L., Hamer M., Wawrzyniak A.J., Steptoe A. The effects of exercise withdrawal on mood and inflammatory cytokine responses in humans. Stress 2011, 14(4):439-447. 10.3109/10253890.2011.557109.
17. Widenfalk J., Olson L., Thorén P. Deprived of habitual running, rats downregulate BDNF and TrkB messages in the brain. Neurosci. Res. 1999, 34:125-132. 10.1016/s0168-0102(99)00051-6.
18. Heyman E., Gamelin F.X., Goekint M., Piscitelli F., Roelands B., Leclair E., Di Marzo V., Meeusen R. Intense exercise increases circulating endocannabinoid and BDNF levels in humans possible implications for reward and depression. Psychoneuroendocrinology 2012, 37(6):844-851. 10.1016/j.psyneuen.2011.09.017.
19. Raichlen D.A., Foster A.D., Gerdeman G.L., Seillier A., Giuffrida A. Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the 'runner's high'. J. Exp. Biol. 2012, 215(Pt 8):1331-1336. 10.1242/jeb.063677.
20. Raichlen D.A., Foster A.D., Seillier A., Giuffrida A., Gerdeman G.L. Exercise-induced endocannabinoid signaling is modulated by intensity. Eur. J. Appl. Physiol. 2013, 113:869-875. 10.1007/s00421-012-2495-5.
21. Tantimonaco M., Ceci R., Sabatini S., Catani M.V., Rossi A., Gasperi V., Maccarrone M. Physical activity and the endocannabinoid system: an overview. Cell. Mol. Life Sci. 2014, 71:2681-2698. 10.1007/s00018-014-1575-6.
22. Hailey B.J., Bailey L.A. Negative addiction in runners: a quantitative approach. J. Sport Behav. 1982, 5:150-154.
23. Rosa D.A., De Mello M.T., Souza-Formigoni M.L.O. Dependência da prática de exercícios físicos: estudo com maratonistas brasileiros. Rev. Bras. Med. Esporte 2003, 9:9-14. 10.1590/S1517-86922003000100003.
24. Hausenblas H.A., Symons Downs D. How much is too much? The development and validation of the exercise dependence scale. Psychol. Health 2002, 17:387-404. 10.1080/0887044022000004894.
25. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, APA, Washington, DC. fourth ed.
26. Berlin A.A., Kop W.J., Deuster P.A. Depressive mood symptoms and fatigue after exercise withdrawal: the potential role of decreased fitness. Psychosom. Med. 2006, 68:224-230. 10.1097/01.psy.0000204628.73273.23.
27. Jones A.M., Doust J.H. A 1% treadmill grade most accurately reflects the energetic cost of outdoor running. J. Sports Sci. 1996, 14:321-327. 10.1080/02640419608727717.
28. Wasserman K., Koike A. Is the anaerobic threshold truly anaerobic?. Chest 1992, 101(5 Suppl.):211S-218S. 10.1378/chest.101.5_Supplement.211S.
29. Carrier J., Monk T.H. Circadian rhythms of performance: new trends. Chronobiol. Int. 2000, 17:719-732. 10.1081/CBI-100102108.
30. Kuipers H., Rietjens G., Verstappen F., Schoenmakers H., Hofman G. Effects of stage duration in incremental running tests on physiological variables. Int. J. Sports Med. 2003, 24:486-491. 10.1055/s-2003-42020.
31. Wagner D.R., Heyward V.H., Gibson A.L. Validation of air displacement plethysmography for assessing body composition. Med. Sci. Sports Exerc. 2000, 32:1339-1344. 10.1097/00005768-200007000-00023.
32. Patterson S.M., Krantz D.S., Montgomery L.C., Deuster P.A., Hedges S.M., Nebel L.E. Automated physical activity monitoring: validation and comparison with physiological and self-report measures. Psychophysiology 1993, 30:296-305. 10.1111/j.1469-8986.1993.tb03356.x.
33. Kop W.J., Lyden A., Berlin A.A., Ambrose K., Olsen C., Gracely R.H., Williams D.A., Clauw D.J. Ambulatory monitoring of physical activity and symptoms in fibromyalgia and chronic fatigue syndrome. Arthritis Rheum. 2005, 52:296-303. 10.1002/art.20779.
34. Balvers M.G., Verhoeckx K.C., Witkamp R.F. Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2009, 877:1583-1590. 10.1016/j.jchromb.2009.04.010.
35. Mcnair D.M., Lorr M., Droppleman L.F. Profile Mood States: Manual 1971, Education and Industrial Testing Service, San Diego.
36. Rohlfs I.C.P.M., Rotta T.M., Luft C.D.B., Andrade A., Krebs R.J., Carvalho T. A Escala de Humor de Brunel (Brums): Instrumento para Detecção Precoce da Síndrome do Excesso de Treinamento. Rev. Bras. Med. Esporte 2008, 14:176-181. 10.1590/S1517-86922008000300003.
37. Morgan W.P. Test of champions: the iceberg profile. Psychology Today 1980, 14:92-108.
38. Brancaccio P., Maffulli N., Buonauro R., Limongelli F.M. Serum enzyme monitoring in sports medicine. Clin. Sports Med. 2008, 27(1-18):vii. 10.1016/j.csm.2007.09.005.
39. Weinstein A.A., Deuster P.A., Kop W.J. Heart rate variability as a predictor of negative mood symptoms induced by exercise withdrawal. Med. Sci. Sports Exerc. 2007, 39:735-741. 10.1249/mss.0b013e31802f590c.
40. Hausenblas H.A., Gauvin L., Symons Downs D., Duley A.R. Effects of abstinence from habitual involvement in regular exercise on feeling states: an ecological momentary assessment study. Br. J. Health Psychol. 2008, 13(Pt 2):237-255. 10.1348/135910707X180378.
41. Aidman E., Woollard S. The influence of self-reported exercise addiction on acute emotional and physiological responses to brief exercise deprivation. J. Sport Exerc. Psychol. 2003, 4:225-236. 10.1016/S1469-0292(02)00003-1.
42. Szabo A. Studying the psychological impact of exercise deprivation: are experimental studies hopeless?. J. Sport Behav. 1998, 21:139-147.
43. Glass M., Dragunow M., Faull R.L. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997, 77:299-318. 10.1016/S0306-4522(96)00428-9.
44. Sparling P.B., Giuffrida A., Piomelli D., Rosskopf L., Dietrich A. Exercise activates the endocannabinoid system. Neuroreport 2003, 14:2209-2211. 10.1097/01.wnr.0000097048.56589.47.
45. Taylor D.V., Boyajian J.G., James N., Woods D., Chicz-Demet A., Wilson A.F., Sandman C.A. Acidosis stimulates beta-endorphin release during exercise. J. Appl. Physiol. (1985) 1994, 77:1913-1918.
46. Dischman R.K., O'Connor P.J. Lessons in exercise neurobiology: the case of endorphins. Mental Health and Physical Activity 2009, 2:4-9. 10.1016/j.mhpa.2009.01.002.
47. Koehl M., Meerlo P., Gonzales D., Rontal A., Turek F.W., Abrous D.N. Exercise-induced promotion of hippocampal cell proliferation requires beta-endorphin. FASEB J. 2008, 22:2253-2262. 10.1096/fj.07-099101.
48. Rahkila P., Hakala E., Alén M., Salminen K., Laatikainen T. Beta-endorphin and corticotropin release is dependent on a threshold intensity of running exercise in male endurance athletes. Life Sci. 1988, 43:551-558. 10.1016/0024-3205(88)90158-0.
49. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31. 10.1016/j.it.2005.11.006.
50. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009, 71(2):171-186. 10.1097/PSY.0b013e3181907c1b.
51. Dantzer R., Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav. Immun. 2007, 21:153-160. 10.1016/j.bbi.2006.09.006.
52. Mujika I., Padilla S. Detraining: loss of training-induced physiological and performance adaptations. Part I: short term insufficient training stimulus. Sports Med. 2000, 30:79-87. 10.2165/00007256-200030020-00002.
53. Mujika I., Padilla S. Cardiorespiratory and metabolic characteristics of detraining in humans. Med. Sci. Sports Exerc. 2001, 33:413-421. 10.1097/00005768-200103000-00013.